A study by Xiong et al., which included 49 coronary artery disease (CAD) patients and 17 CAD-free subjects, found a negative association between soluble lymphocyte activation gene 3 (sLAG3) levels and CAD occurrence, but no correlation with disease severity (29).. Here, LAG3 is linked to coronary artery disorder.